1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using...
-
Upload
katelyn-daniels -
Category
Documents
-
view
221 -
download
0
Transcript of 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using...
![Page 1: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/1.jpg)
1
CHAPTER 3
PHARMACOKINETIC MODELS
![Page 2: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/2.jpg)
2
PHARMACOKINETIC MODELING
A Model is a hypothesis using mathematical terms to describe quantitative relationships
MODELING REQUIRES:Thorough knowledge of anatomy and
physiologyUnderstanding the concepts and limitations
of mathematical models. Assumptions are made for simplicity
![Page 3: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/3.jpg)
3
OUTCOME
The development of equations to describe drug concentrations in the body as a function of timeHOW?
By fitting the model to the experimental data known as variables.
A PK function relates an independent variable to a dependent variable.
![Page 4: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/4.jpg)
4
FATE OF DRUG IN THE BODY
ADME
Oral
Administration
G.I.
Tract
Circulatory
System
Intravenous
Injection
TissuesMetabolic
Sites
Intramuscular
Injection
Subcutaneous
Injection
Exc
reti
on
![Page 5: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/5.jpg)
5
Complexity of PK model will vary with:
1- Route of administration2- Extent and duration of distribution into various body fluids and tissues.3- The processes of elimination.4- Intended application of the PK model.
We Always Choose the SIMPLEST Model
![Page 6: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/6.jpg)
6
Types of PK Models
1- Physiologic (Perfusion) Models
2- Compartmental Models
3- Mammillary Models
![Page 7: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/7.jpg)
7
PHYSILOGIC PK MODELS
Models are based on known physiologic
and anatomic data.
Blood flow is responsible for distributing
drug to various parts of the body.
Each tissue volume must be obtained and
its drug conc described.
Predict realistic tissue drug conc
Applied only to animal species and human
data can be extrapolated.
![Page 8: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/8.jpg)
8
PHYSILOGIC PK MODELS
Can study how physiologic factors may change drug distribution from one animal species to another
No data fitting is required Drug conc in the various tissues are predicted
by organ tissue size, blood flow, and experimentally determined drug tissue-blood ratios.
Pathophysiologic conditions can affect distribution.
![Page 9: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/9.jpg)
9
Physiological Model Simulation
Perfusion Model Simulation of Lidocaine IV Infusion in Man
Blood
Metabolism
RET
Muscle
AdiposeLung
Time
Per
cen
t o
f D
ose
![Page 10: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/10.jpg)
10
COMPARTMENTAL MODELS
The body is represented by a series of compartments that communicate reversibly with each other.
1 2 3
21
k12
k21
![Page 11: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/11.jpg)
11
COMPARTMENTAL MODELS A compartment is not a real physiologic or
anatomic region, but it is a tissue or group
of tissues having similar blood flow and drug
affinity. Within each compartment the drug is considered
to be uniformly distributed. Drug move in and out of compartments Compartmental models are based on linear
differential equations. Rate constants are used to describe drug entry
into and out from the compartment.
![Page 12: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/12.jpg)
12
COMPARTMENTAL MODELS
The model is an open system since drug is
eliminated from the system. The amount of drug in the body is the sum
of drug present in the compartments. Extrapolation from animal data is not
possible because the volume is not a true
volume but is a mathematical concept. Parameters are kinetically determined from
the data.
![Page 13: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/13.jpg)
13
MAMMILLARY MODELSIs the most common compartmental model used in PK. The model consists of one or more
compartments connected to a central compartment
2 1 3
1ka kel
21
k12
k21
![Page 14: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/14.jpg)
14
Intravenous and Extravascular AdministrationIV, IM, SC
![Page 15: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/15.jpg)
15
Intravenous and extravascular Route of
AdministrationDifference in plasma conc-time curve
Intravenous
Administration
Extravascular
Administration
Time
Cp
Time
Cp
![Page 16: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/16.jpg)
16
One Compartment Open Model Intravenous
Administration
![Page 17: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/17.jpg)
17
One Compartment Open Model Intravenous
AdministrationThe one compartment model offers the simplest way to describe the process of drug distribution and elimination in the body.
When the drug is administered i.v. in a single rapid injection, the process of absorption is bypassed
Blood (Vd)
i.v. Input
kel
Output
![Page 18: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/18.jpg)
18
One Compartment Open Model Intravenous
AdministrationThe one-compartment model does not predict actual drug levels in the tissues, but does imply that changes in the plasma levels of a drug will result in proportional changes in tissue drug levels.
![Page 19: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/19.jpg)
19
FIRST-ORDER KINETICS The rate of elimination for most drugs is a
first-order process.
kel is a first-order rate constant with a unit
of inverse time such as hr-1.
![Page 20: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/20.jpg)
20
Semi-log paper
Plotting the data
![Page 21: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/21.jpg)
21
INTEGRATED EQUATIONSThe rate of change of drug plasma conc over time is equal to:
This expression shows that the rate of elimination of drug from the body is a first-order process and depends on kel
pelp Ck
dt
dC
![Page 22: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/22.jpg)
22
INTEGRATED EQUATIONS
pelp Ck
dt
dC
Cp = Cp0e-kelt
ln Cp = ln Cp0 kelt
DB = Dose . e-kelt
ln DB = ln Dose kelt
![Page 23: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/23.jpg)
23
Elimination Half-Life (t1/2)
Is the time taken for the drug conc or the amount in the body to fall by one-half, such as Cp = ½ Cp0 or DB = ½ DB
0
Therefore,
elkt
693.02/1
![Page 24: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/24.jpg)
24
ESTIMATION OF half-life from graph
A plot of Cp vs. time
t1/2 = 3 hr
![Page 25: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/25.jpg)
25
Fraction of the Dose Remaining
The fraction of the dose remaining in the body (DB /Dose) varies with time.
The fraction of the dose lost after a time t can be then calculated from:
tkB eleDose
D
tkele 1
![Page 26: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/26.jpg)
26
Volume of Distribution (Vd)Is the volume in which the drug is dissolved in the body.Example: 1 gram of drug is dissolved in an unknown volume of water. Upon assay the conc was found to be 1mg/ml. What is the original volume of the solution?
V = Amount / Conc = 1/1= 1 literAlso, if the volume and the conc are known, then the original amount dissolved can be calculated
Amount = V X Conc= 1X1= 1 gram
![Page 27: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/27.jpg)
27
Apparent Vd
It is called apparent because it does not have any physiological meaning. Drugs that are highly lipid soluble, such as digoxin has a very high Vd (600 liters), drugs which are lipid insoluble remain in the blood and have a low Vd.
For digoxin, if that were a physiological space and I were all water, that would weigh about 1320 lb (599 kg).
![Page 28: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/28.jpg)
28
Apparent Vd
Vd is the ratio between the amount of drug in the body (dose given) and the concentration measured in blood or plasma.
Therefore, Vd is calculated from the equation:
Vd = DB / CP
where,
DB = amount of drug in the body
Cp = plasma drug concentration
![Page 29: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/29.jpg)
29
For One Compartment Model with IV Administration:
With rapid IV injection the dose is equal to the amount of drug in the body at zero time (DB).
Where Cp is the intercept obtained by plotting Cp vs. time on a semilog paper.
p
B
pd C
D
C
DoseV
![Page 30: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/30.jpg)
30
For One Compartment Model with IV Administration:
p
B
pd C
D
C
DoseV
Cpo
![Page 31: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/31.jpg)
31
Calculation of Vd from the AUC
Since, dDB/dt = -kelD = -kelVdCp
dDB = -kelVdCpdt
dDB = -kelVd Cpdt
Since, Cpdt = AUC
Then, AUC = Dose / kelVd
ModelIndependent
Method][AUCk
DoseV
eld
![Page 32: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/32.jpg)
32
Significance of Vd
Drugs can have Vd equal, smaller or greater than
the body mass
Drugs with small Vd are usually confined to the
central compartment or highly bound to plasma
proteins
Drugs with large Vd are usually confined in the
tissue
Vd can also be expressed as % of body mass and
compared to true anatomic volume
Vd is constant but can change due to pathological
conditions or with age
![Page 33: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/33.jpg)
33
Apparent Vd
Example: if the Vd is 3500 ml for a subject weighing 70 kg, the Vd expressed as percent
of body weight would be:
weightbodyofKg
Kg%5100
70
5.3
The larger the apparent Vd, the greater the amount of drug in the extravascular tissues. Note that the plasma represents about 4.5% of the body weight and total body water about 60% of body weight.
![Page 34: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/34.jpg)
34
CLEARANCE (Cl)Is the volume of blood that is cleared of drug per unit time (i.e. L/hr). Cl is a measure of drug elimination from the body without identifying the mechanism or process. Cl for a first-order elimination process is constant regardless of the drug conc.
eldkVCl Cl
DoseAUC
0
![Page 35: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/35.jpg)
35
INTEGRATED EQUATIONS
0p
d C
DoseV
elkt
693.02/1
pCl
DoseAUC
el
p
k
CAUC
0
eldp kVCl
tkpp
eleCC 0 tkB
eleDoseD
tkCC elpp 0lnln tkDoseD elB lnln
![Page 36: 1 CHAPTER 3 PHARMACOKINETIC MODELS. 2 PHARMACOKINETIC MODELING A Model is a hypothesis using mathematical terms to describe quantitative relationships.](https://reader033.fdocuments.net/reader033/viewer/2022061305/5514458e5503462d4e8b4b75/html5/thumbnails/36.jpg)
36
ESTIMATION OF PK PARAMETERS
A plot of Cp vs. time
kel
Cpo